13 C-Labeled ethylene polymerization (pre)catalysts [κ 2 -(anisyl) 2 P,O ]Pd( 13 CH 3 )(L) ( 1- 13 CH 3 -L ) (L = pyridine, dmso) based on di(2-anisyl)phosphine benzenesulfonate were used to assess the degree of incorporation of 13 CH 3 groups into the formed polyethylenes. Polymerizations of variable reaction time reveal that ca. 60–85% of the 13 C-label is found in the polymer after already 1 min polymerization time, which provides evidence that the pre-equilibration between the catalyst precursor 1- 13 CH 3 -L and the active species 1- 13 CH 3 -(ethylene) is fast with respect to chain growth. The fraction of 1- 13 CH 3 -L that initiates chain growth is likely higher than the 60–85% determined from the 13 C-labeled polymer chain ends since (a) chain walking results in in-chain incorporation of the 13 C-label, (b) irreversible catalyst deactivation by formation of saturated (and partially volatile) alkanes diminishes the amount of 13 CH 3 groups incorporated into the polymer, and (c) palladium-bound 13 CH 3 groups, and more general palladium-bound alkyl(polymeryl) chains, partially transfer to phosphorus by reductive elimination. NMR and ESI-MS analyses of thermolysis reactions of 1- 13 CH 3 -L provide evidence that a mixture of phosphonium salts ( 13 CH 3 ) x P + (aryl) 4– x ( 2 – 7 ) is formed in the absence of ethylene. In addition, isolation and characterization of the mixed bis(chelate) palladium complex [κ 2 -(anisyl) 2 P,O ]Pd[κ 2 -(anisyl)( 13 CH 3 ) P,O ] ( 11 ) by NMR and X-ray diffraction analyses from these mixtures indicate that oxidative addition of phosphonium salts to palladium(0) species is also operative. The scrambling of palladium-bound carbyls and phosphorus-bound aryls is also relevant under NMR, as well as preparative reactor polymerization conditions exemplified by the X-ray diffraction analysis of [κ 2 -(anisyl) 2 P, O ]Pd[κ 2 - (anisyl)(CH 2 CH 3 ) P,O ] ( 12 ) and [κ 2 -(anisyl) 2 P,O ]Pd[κ 2 -(anisyl)((CH 2 ) 3 CH 3 ) P,O ] ( 13 ) isolated from pressure reactor polymerization experiments. In addition, ESI-MS analyses of reactor polymerization filtrates indicate the presence of (odd- and even-numbered alkyl)(anisyl)phosphine sulfonates ( 14 ) and their respective phosphine oxides ( 15 ). Furthermore, 2-(vinyl)anisole was detected in NMR tube and reactor polymerizations, which results from ethylene insertion into a palladium–anisyl bond and concomitant β-hydride elimination. In addition to these scrambling reactions, formation of alkanes or fully saturated polymer chains, bis(chelate)palladium complexes [κ 2 - P,O ] 2 Pd, and palladium black was identified as an irreversible catalyst deactivation pathway. This deactivation proceeds by reaction of palladium alkyl complexes with palladium hydride complexes [κ 2 - P,O ]Pd(H)(L) or by reaction with the free ligand H[P,O] generated by reductive elimination from [κ 2 - P,O ]Pd(H)(L). The model hydride complex 1-H-P t Bu 3 has been synthesized in order to establish whether 1-H-P t Bu 3 or H[P,O] is responsible for the irreversible catalyst deactivation. However, upon reaction with 1- (13) CH 3 -L or 1-CH 2 CH 3 -PPh 3, both 1-H-P t Bu 3 and H[P,O] result in formation of methane or ethane, even though H[P,O] reacts faster than 1-H-P t Bu 3 . DFT calculations show that reductive elimination to form H[P,O] and (alkyl)[P,O] from 1-H/(alkyl)-P t Bu 3 is kinetically accessible, as is the oxidative readdition of the P–H bond of H[P,O] and the P–anisyl bond of (alkyl)[P,O] to [Pd(P t Bu 3 ) 2 ]. These calculations also indicate that for a reaction sequence comprising reductive elimination of H[P,O] from 1-H-P t Bu 3 and reaction of H[P,O] with 1-CH 3 -P t Bu 3, 1-CH 3 -dmso, or 1-CH 2 CH 3 -PPh 3 to form methane or ethane, the rate-limiting step is reductive elimination of H[P,O] with a barrier of 124 kJ mol –1 . However, a second reaction coordinate was found for the reaction of 1-H-P t Bu 3 with 1-CH 3 -P t Bu 3 or 1-CH 3 -dmso, which evolves into bimetallic transition-state geometries with a nearly linear H-(CH 3 )-Pd alignment and which exhibits a barrier of 131 or 95 kJ mol –1 for the formation of methane.
No takes yet. Share an insight, caveat, or question.
Rünzi et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: